These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21194767)

  • 1. Significant intimal hyperplasia regression between 6 and 18 months following Genous™ endothelial progenitor cell capturing stent placement.
    Klomp M; Beijk MA; Tijssen JG; de Winter RJ
    Int J Cardiol; 2011 Mar; 147(2):289-91. PubMed ID: 21194767
    [No Abstract]   [Full Text] [Related]  

  • 2. Genous endothelial progenitor cell-capturing stent system: a novel stent technology.
    Klomp M; Beijk MA; de Winter RJ
    Expert Rev Med Devices; 2009 Jul; 6(4):365-75. PubMed ID: 19572791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
    Silber S; Damman P; Klomp M; Beijk MA; Grisold M; Ribeiro EE; Suryapranata H; Wójcik J; Hian Sim K; Tijssen JG; de Winter RJ
    EuroIntervention; 2011 Feb; 6(7):819-25. PubMed ID: 21252015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of endothelial progenitor cell capture stent for treatment of left main coronary artery disease before non-cardiac surgery for abdominal aortic aneurysm.
    Ho HH; Chow WH; Ko LY; Jim MH
    Int J Cardiol; 2010 Aug; 143(2):e27-9. PubMed ID: 19135732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of endothelial progenitor cell capture stent in a de novo lesion previously covered by vascular brachytherapy.
    Jim MH; Yiu KH; Chow WH
    Int J Cardiol; 2011 Apr; 148(2):233-4. PubMed ID: 19880205
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
    Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
    J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
    Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
    Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics.
    Egan CG; Caporali F; Huqi AF; Zito MC; Focardi M; Mondillo S; Pierli C; Marzilli M; Sorrentino V
    Thromb Haemost; 2009 Jun; 101(6):1138-46. PubMed ID: 19492159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.
    George J; Herz I; Goldstein E; Abashidze S; Deutch V; Finkelstein A; Michowitz Y; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e57-60. PubMed ID: 14615392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelial cells and their progenitors in intimal hyperplasia.
    Patel SD; Waltham M; Wadoodi A; Burnand KG; Smith A
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):129-41. PubMed ID: 20200200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone reduces restenosis after stenting of small coronary arteries.
    Kakio T; Matsumori A; Ohashi N; Yamada T; Saito T; Kawamoto A; Taguchi A; Morita Y; Takahashi M; Sasayama S
    J Interv Cardiol; 2004 Oct; 17(5):295-300. PubMed ID: 15491332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registry.
    Scacciatella P; Meliga E; D'Amico M; Amato G; Pennone M; Conrotto F; Marra S
    EuroIntervention; 2011 Feb; 6(7):826-30. PubMed ID: 21252016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical effects of magnetic resonance imaging in patients with coronary artery stent implantation.
    Kaya MG; Okyay K; Yazici H; Sen N; Tavil Y; Turkoglu S; Timurkaynak T; Ozdemir M; Cemri M; Yalcin R; Cengel A
    Coron Artery Dis; 2009 Mar; 20(2):138-42. PubMed ID: 19247183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractured DES with a patent coronary artery: clinical implications.
    Park JS; Shin DG; Kim YJ
    J Invasive Cardiol; 2007 Feb; 19(2):E43-5. PubMed ID: 17268051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.